Who owns ABIONYX Pharma?

ABIONYX Pharma is formerly owned by Sofinnova Partners, through Sofinnova Capital VI, since 2010.

When did Sofinnova Partners acquire ABIONYX Pharma?

Sofinnova Partners acquired ABIONYX Pharma in 2010 and exited after 10 years.

Has ABIONYX Pharma been sold?

Yes. ABIONYX Pharma was exited in 2020 via IPO.

Home/Companies/Biotech/ABIONYX Pharma

ABIONYX Pharma

Biotech·

France·Exited 2020·Held 10yr

ABIONYX Pharma is a healthcare / biotech company, headquartered in France.

Entry

2010

Hold

10yr

Exit

2020

Est. EV

–

Investor

Sofinnova Partners

Key facts

HQFrance

SectorHealthcare / Biotech

Biopharmaceutical company (formerly Cerenis). Reverse merger/restructuring in 2020 Listed on Euronext Paris (ABNX, formerly Cerenis…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Exit details: type, year, MOIC (buyer on Pro)

Start free

Already a member? Sign in

More from Sofinnova Capital VI

Other portfolio companies in the same fund.

Omthera Pharmaceuticals

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings